Literature DB >> 34088365

Silica embedded carbon nanosheets derived from biomass acorn cupule for non-enzymatic, label-free, and wide range detection of α 1-acid glycoprotein in biofluids.

Lignesh Durai1, Arthi Gopalakrishnan1, Sushmee Badhulika2.   

Abstract

In this work, we demonstrate the first report on a low-cost, non-enzymatic, label-free electrochemical sensing of alpha-1-acid-glycoprotein (α1GP) biomarker in biofluids using silica embedded carbon nanosheets (SEC) derived from acorn cupules biomass. The SEC/GCE sensor exhibits low detection limit (LOD) of 30 ng/mL (LOD = 3 s/m) which is far below the lowest physiological concentration of α1GP and a wide linear detection range from 100 ng/mL to 10 mg/mL which covers entire clinical concentration range reported for various diseases like cancer, sepsis, etc. The sensing mechanism of the sensor relies on the direct electrooxidation of sialic acid from the α1GP structure which hinder the interfacial electron-transfer process of [Fe (CN)6]3-/4- redox probe at the electrode-electrolyte interface. The sensor exhibits excellent selectivity and stability towards detection of α1GP which is ascribed to the presence of embedded silica nanoparticles on the surface of the carbon nanosheets. The successful determination of α1GP in the simulated blood serum sample with good recovery percentage (i.e., from ∼94.03% to ∼103.50%) proves the feasibility of the sensor towards clinical applications. The overall efficacy of the sensor proves it as a promising low-cost, sustainable, and non-enzymatic platform for a wide variety of bioanalytical applications.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alpha-1-acid- glycoprotein; Biomass-carbon; Direct-electrooxidation; Electrochemical sensor; Non-enzymatic; Silica-embedded

Year:  2021        PMID: 34088365     DOI: 10.1016/j.aca.2021.338598

Source DB:  PubMed          Journal:  Anal Chim Acta        ISSN: 0003-2670            Impact factor:   6.558


  1 in total

1.  Potential use of Cypridina luciferin for quantifying alpha 1-acid glycoprotein in human serum.

Authors:  Shusei Kanie; Yasuo Mitani
Journal:  Anal Sci       Date:  2022-10-07       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.